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Background: Streptococcus pneumoniae is the main pathogen that causes respiratory infections in children younger
than five years. The increasing incidence of macrolide- and tetracycline-resistant pneumococci among children
has been a serious problem in China for many years. The molecular characteristics of erythromycin-resistant
pneumococcal isolates that were collected from pediatric patients younger than five years in Beijing in 2010
were analyzed in this study.
Results: A total of 140 pneumococcal isolates were collected. The resistance rates of all isolates to erythromycin
and tetracycline were 96.4% and 79.3%, respectively. Of the 135 erythromycin-resistant pneumococci, 91.1% were
non-susceptible to tetracycline. In addition, 30.4% of the erythromycin-resistant isolates expressed both the ermB
and mef genes, whereas 69.6% expressed the ermB gene but not the mef gene. Up to 98.5% of the resistant
isolates exhibited the cMLSB phenotype, and Tn6002 was the most common transposon present in approximately
56.3% of the resistant isolates, followed by Tn2010, with a proportion of 28.9%. The dominant sequence types (STs)
in all erythromycin-resistant S. pneumoniae were ST271 (11.9%), ST81 (8.9%), ST876 (8.9%), and ST320 (6.7%),
whereas the prevailing serotypes were 19F (19.3%), 23F (9.6%), 14 (9.6%), 15 (8.9%), and 6A (7.4%). The 7-valent
pneumococcal conjugate vaccine (PCV7) and 13-valent pneumococcal conjugate vaccine (PCV13) coverage of
the erythromycin-resistant pneumococci among the children younger than five years were 45.2% and 62.2%,
respectively. ST320 and serotype 19A pneumococci were common in children aged 0 to 2 years. CC271 was
the most frequent clonal complex (CC), which accounts for 24.4% of all erythromycin-resistant isolates.
Conclusions: The non-invasive S. pneumoniae in children younger than five years in Beijing presented high and
significant resistance rates to erythromycin and tetracycline. The expressions of ermB and tetM genes were the main
factors that influence pneumococcal resistance to erythromycin and tetracycline, respectively. Majority of the
erythromycin-resistant non-invasive isolates exhibited the cMLSB phenotype and carried the ermB, tetM, xis, and int
genes, suggesting the spread of the transposons of the Tn916 family. PCV13 provided higher serotype coverage in
the childhood pneumococcal diseases caused by the erythromycin-resistant isolates better than PCV7. Further
long-term surveys are required to monitor the molecular characteristics of the erythromycin-resistant S. pneumoniae
in children.* Correspondence: yyh66@vip.sina.com
†Equal contributors
Key Laboratory of Major Diseases in Children and National Key Discipline of
Pediatrics (Capital Medical University), Ministry of Education, Beijing Pediatric
Research Institute, Beijing Children’s Hospital, Capital Medical University,
No. 56 Nan-li-shi Road, Beijing 100045, China
© 2012 Zhou et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Zhou et al. BMC Microbiology 2012, 12:228 Page 2 of 10
http://www.biomedcentral.com/1471-2180/12/228Background
Streptococcus pneumoniae, the main pathogen that
causes respiratory infections in children younger than
five years, can cause various pneumococcal diseases,
such as otitis media, sinusitis, pneumonia, meningitis,
pleurisy, and bacteremia. Pneumococcal disease has been
a major public health problem worldwide. In 2005, the
World Health Organization (WHO) estimated that 1.6
million people die of pneumococcal diseases annually,
of which the deaths of 0.7 million to 1 million were
children younger than five years [1].
Antibiotics are often the first treatment of choice
for pneumococcal infections. However, the increasing re-
sistance of S. pneumoniae to various antibiotics, includ-
ing macrolides and tetracyclines, makes pneumococcal
infections difficult to treat especially in children and in
regions like China. The resistance rate of S. pneumoniae
to erythromycin and to tetracycline among children
younger than five years in Beijing ranged from 87% to
94% and above 80%, respectively [2]. Pneumococcal
macrolide resistance is mediated by two major mechan-
isms, namely, target modification by a ribosomal methy-
lase encoded by the ermB gene and drug efflux encoded
by the mef gene. In S. pneumoniae, the tetracycline resist-
ance is a result of the acquisition of one of the two genes,
tetM or tetO, both of which encode ribosome protection
proteins [3,4]. Pneumococcal resistance to erythromycin
and tetracycline is frequently associated with the insertion
of the ermB gene into the transposons of the Tn916 or
Tn917 family (Tn6002, Tn2010, Tn3872, Tn1545, and
Tn6003) that contains the tetM gene.
Resistant-clonal isolates are distributed in different
countries and regions, which results in the spread of
bacterial resistance. The molecular epidemiological mon-
itoring network (http://spneumoniae.mlst.net/pmen/) has
published 43 international clones of S. pneumoniae,
among which the clones of serotypes 6A, 6B, 14, 15A,
19A, 19F, 23F, and 35B were found to be associated with
bacterial resistance. Thus, a study on the molecular epi-
demiology of S. pneumoniae for children in one region
is beneficial to monitor pneumococal-resistant clones.
Studies on the characteristics of erythromycin-resistant
S. pneumoniae in China are rare. Thus, the present
study focuses on analyzing the phenotypic and genotypic
characteristics of erythromycin-resistant pneumococcal
isolates from pediatric patients in Beijing in 2010 as well
as their respective relationships.
Methods
Bacterial isolates
A total of 140 S. pneumoniae isolates were collected
from the nasopharyngeal swabs of pediatric patients
younger than five years with upper respiratory infections
in the Beijing Children’s Hospital in 2010 after theirparents or legal guardians have given their consent. The
study was approved by the Ethics Committee of the
Beijing Children’s Hospital, and all procedures were per-
formed in accordance with the Helsinki Declaration [5].
The isolates were identified based on the typical colony
morphology, Gram staining, optochin sensitivity test
(Oxoid Company, Britain), and Omni serum assay
(Statens Serum Institut, Copenhagen, Denmark). Only
one isolate was selected from the same subject. Of the
140 S. pneumoniae isolates, 57 were obtained from
pediatric patients aged 0 to 2 years (≤2 years old) and 83
from those aged 2 years to 5 years (>2 but ≤5 years old).
Antibiotic susceptibility testing
The E-test (AB Biodisk, Sweden) method was performed
to determine the antibiotic susceptibility of the 140
pneumococcal isolates to erythromycin and tetracycline
according to the guidelines established by the Clinical
and Laboratory Standards Institute (CLSI). The CLSI
2010 criteria [6] for minimum inhibitory concentrations
(MICs) were applied to classify the susceptible, inter-
mediate, or resistant isolates with the following break-
points: erythromycin, ≤0.25 μg/mL, 0.5 μg/mL, and
≥1 μg/mL; and tetracycline, ≤2 μg/mL, 4 μg/mL, and
≥8 μg/mL, respectively. ATCC49619 was used as the
quality control strain and was included in each set of
tests to ensure accurate results.
Macrolide resistance phenotype
Macrolide resistance phenotyping was performed via
double-disk diffusion using standard disks of erythro-
mycin (15 μg) and clindamycin (2 μg) (Oxoid Company,
Britain). A blunting of the clindamycin inhibition zone
adjacent to the erythromycin disk (“D zone”) indicated
the presence of the inducible macrolide-resistant pheno-
type (iMLSB), whereas the absence of blunting indicated
the presence of the constitutive macrolide-resistant
phenotype (cMLSB). The M macrolide phenotype was
characterized by clindamycin susceptibility with no blunt-
ing of the inhibition zone around the clindamycin disk.
DNA extraction
Chromosomal DNA was isolated from the overnight cul-
tures of the isolates that were grown on 5% trypticase
soy agar by using the DNA Mini Kit (SBS Genetech,
Beijing) according to the manufacturer’s instructions.
Detection of genes and related transposons
The macrolide-resistance genes ermB and mef were
detected using polymerase chain reaction (PCR) with
oligonucleotide primers specific for each gene as
described in the previous studies [7]. The PCR products
of the mef genes were digested with BamHI to distin-
guish the mefA and mefE gene subclasses [8].
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xis, tnpA, and tnpR), the tetracycline-resistance gene
tetM, and the promoter of the aph3’-III gene were
detected by PCR using the primers described in previous
studies [9-13]. The resistance gene combinations related
to the different presumed transposons were Tn6002
(ermB, tetM, int, and xis), Tn2010 (ermB, tetM, int, xis,
and mefE), Tn3872 (ermB, tetM, tnpA, and tnpR),
Tn1545, or Tn6003 (ermB, tetM, int, xis, and aph3’-III).
Multi locus sequence typing (MLST)
The housekeeping genes aroE, gdh, gki, recP, spi, xpt,
and ddl were amplified via PCR [14]. The sequences of
each of the seven loci were compared with those of all
known alleles at the loci as well as with the STs in the
database of the pneumococcal multi locus sequence typing
(MLST) website (http://spneumoniae.mlst.net). New allelic
numbers or new ST numbers were assigned by the curator
of the pneumococcal MLST website. The eBURST v3 soft-
ware (http://spneumoniae.mlst.net/eburst/) was used to
investigate the relationships between the isolates and to
assign a clonal complex (CC) based on the stringent group
definition of six out of seven shared alleles.
Serotyping
Pneumococcal serotyping was performed through the
Quellung reaction by using Pneumotest kits and type-
specific antisera (Statens Serum Institut, Copenhagen,
Denmark) for the erythromycin-resistant isolates as previ-
ously described [15]. The isolates that reacted negatively
were non-typeable. The PCV7 and PCV13 coverage was
estimated by calculating the percentage of isolates that
expressed the serotypes included in the vaccine.
Statistical analysis
The data from the antibiotic susceptibility testing were
set up and analyzed using the WHONET 5.3 software,
which was recommended by the WHO. The χ2-test and
the Fisher’s accurate probability tests were performed
using the SPSS version 13.0 software to compare propor-




The susceptibility and MICs to erythromycin and tetra-
cycline of 140 pneumococcal isolates that were collected
among children of different ages are presented in Table 1.
Based on the CLSI 2010 criteria, the resistance rate of
all isolates to erythromycin was 96.4% (135/140),
whereas the susceptibility rate was merely 2.9% (4/140).
Up to 98.5% (133/135) of the erythromycin-resistant
pneumococcal isolates exhibited high MICs (>256 μg/mL).
The erythromycin resistance rates between children aged0 to 2 years and 2 to 5 years were all above 94.0%, with
54 and 81 isolates, respectively. No significant difference
was found between the two age groups (P> 0.05). The
total resistance rate of all the isolates to tetracycline
reached 79.3% (111/140). No difference was also found
in tetracycline resistance between children aged 0 to
2 years and 2 to 5 years (P> 0.05). A total of 110 (78.6%)
isolates were resistant to both erythromycin and tetra-
cycline, and 91.1% (123/135) of the erythromycin-
resistant strains were non-susceptible (intermediate and
resistant) to tetracycline.
Detection of resistance genes and phenotype
All 135 erythromycin-resistant isolates were detected for
macrolide- and tetracycline-resistance genes as well as
macrolide-resistant phenotype. Almost 30.4% isolates
expressed both the ermB and mef genes, whereas 69.6%
were positive for the ermB gene but negative for the mef
gene. The resistant isolates had no different carrying
proportions of both the ermB and mef genes, as well as
only ermB, between the two aforementioned pediatric
age groups (P > 0.05) (Table 2). All mef-positive isolates
carried the mefE gene. Among the erythromycin-
resistant pneumococcal isolates, all the 123 tetracycline-
resistant and intermediate isolates carried the tetM gene.
However, eight of the 12 tetracycline-susceptible isolates
carried the tetM gene. Up to 98.5% (133/135) of the
resistant isolates exhibited the cMLSB phenotype, but
only two isolates expressed the M phenotype. No iMLSB
phenotype was found among the resistant isolates.
Transposon distribution
Among the 135 erythromycin-resistant pneumococci,
76 isolates (56.3%) contained ermB, tetM, int, and xis
genes related to Tn6002. 39 isolates (28.9%) were
detected for the presence of ermB, tetM, int, xis, and
mefE genes, carrying the transposon of Tn2010. Seven
isolates (5.2%) were positive for the ermB, tetM, tnpA,
and tnpR genes related to Tn3872. Eight isolates (5.9%)
containing the ermB, tetM, int, and xis genes were also
positive for the promoter of the aph3’-III gene related
to Tn1545/6003 via PCR, of which only two isolates
had the mefE gene. The int, xis, tnpA, tnpR, aph3’-III,
and mefE genes were not detected in the remaining five
isolates (3.7%) (Figure 1).
Multi locus sequence typing
A total of 62 STs were found in the erythromycin-
resistant S. pneumoniae, of which 28 STs were newly
assigned, via MLST analysis. Of the new STs, 19 types
were novel combinations of known alleles (ST6875,
ST6946, and ST7746 to ST7762). Up to 9 profiles
(ST7763 to ST7770 and ST7869) contained 10 new
alleles, namely, aroE236, gdh353, gki353, gki354, gki355,
Table 1 Susceptibility and minimum inhibitory concentrations (MICs) of 140 S. pneumoniae isolates to erythromycin
and tetracycline






0 to 2 years 57 erythromycin 3 (5.3%) 0 (0%) 54 (94.7%) >256 >256 0.125- > 256
tetracycline 9 (15.8%) 5 (8.8%) 43 (75.4%) 12 16 0.064-16
2 to 5 years 83 erythromycin 1 (1.2%) 1 (1.2%) 81 (97.6%) >256 >256 0.125- > 256
tetracycline 6 (7.3%) 9 (10.8%) 68 (81.9%) 12 16 0.094-32
0 to 5 years 140 erythromycin 4 (2.9%) 1 (0.7%) 135 (96.4%) >256 >256 0.125- > 256
tetracycline 15 (10.7%) 14 (10.0%) 111 (79.3%) 12 16 0.064-32
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predominant STs of all resistant pneumococci were
ST271 (11.9%, 16/135), ST81 (8.9%, 12/135), ST876
(8.9%, 12/135), and ST320 (6.7%, 9/135) (Figure 2). Of
the common STs, the proportion of ST320 was higher
among children aged 0 to 2 years than that of the other
age group (P < 0.05). However, the percentage of the
other STs, such as ST81, ST236, ST271, ST876, ST386,
and ST2572, did not show any difference between the
two age groups (P > 0.05). The eBURST analysis results
showed 9 CCs and 36 singletons (Figure 3). CC271 was
the most frequent CC, with a proportion of 24.4%
(33/135) among the resistant isolates.Serotyping and vaccine coverage
Among the 135 erythromycin-resistant pneumococci,
121 isolates (89.6%) could be serotyped, of which the
prevailing five serotypes were 19F (19.3%), 23F (9.6%),
14 (9.6%), 15 (8.9%), and 6A (7.4%), which accounted for
54.8% (74/135). The pneumococcal isolates of serotype
19A were significantly common among children aged 0
to 2 years than that of 2 to 5 years (P < 0.05). However,
the pneumococcal isolates of the other serotypes were
not different between the two age groups (P > 0.05). The
PCV13 coverage for the erythromycin-resistant isolates
was 62.2% (84/135). This value was higher than that of
PCV7 (45.2%, 61/135) among all children younger than
five years as well as the children aged 0 to 2 years
(P < 0.05). The PCV7 coverage of children aged 2 to
5 years was significantly higher than that of 0 to 2 years
(P < 0.05). However, no difference in PCV13 coverage
was observed among these two age groups (P > 0.05)
(Figure 4).Table 2 Detection of erythromycin-resistance genes for 135 e
Macrolide-resistance genes No. (%) Age group
ermB mef 0 to 2 years 2 to 5 y
+ + 41 (30.4%) 18 (13.3%) 23 (17.1
+ - 94 (69.6%) 36 (26.7%) 58 (42.9Relations of sequence types, serotypes, resistance genes,
and transposons
Several associations were observed between the STs,
serotypes, macrolide-resistance genes, as well as Tn916-
and Tn917-related transposons for the erythromycin-
resistant pneumococcal isolates (Table 3). The dominant
ST of the serotype 19F isolates was ST271, followed by
ST236. On the other hand, that of the serotype 14, 23F,
and 6B isolates was ST876, ST81, and ST386, respect-
ively. The ST of all the serotype 19A pneumococci was
ST320. All isolates of CC271, which was identified as
serotype 19F and 19A, carried two macrolide-resistance
genes, ermB and mefE. However, the mefE gene was not
found among the isolates of other CCs, such as CC2754,
CC230, CC3173, CC3397, CC6202, and CC855. Tn6002
was distributed among the isolates of seven CCs except
for CC271 and CC3173, among which the dominant
transposons were Tn2010 and Tn3872, respectively.
Tn1545/6003 was found in the isolates of ST180, ST271,
ST320, ST505, ST2572, ST7759, ST7760, and ST7768.Discussion
S. pneumoniae is a Gram-positive encapsulated diplococ-
cus and is often transmitted by direct contact with re-
spiratory secretions from the infected and healthy
carriers. The disease develops by contiguous spread to
the sinuses or the middle ear, aspiration into the lower
respiratory tract, which causes pneumonia, or by inva-
sion into the bloodstream with or without the seeding of
secondary sites. According to the 2000 Chinese census
data, an estimated 260,768 (113,000 to 582,382) pneu-
monia and 902 (114 to 4,463) meningitis cases were
caused by S. pneumoniae. The estimated deaths fromrythromycin-resistant pneumococcal isolates
MICs (μg/mL) distribution (No.) MIC range (μg/mL)
ears 3 12 >256
%) 1 1 39 3- > 256
%) 94 >256





Figure 1 Distribution of Tn916- and Tn917-related transposons in the 135 erythromycin-resistant pneumococcal isolates.
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(4,638 to 23,904) and 75 (10 to 370), respectively [16].
This result indicates that pneumococcal diseases are a
significant health problem among children in China.
Pneumococcal resistance to antimicrobials, such as
macrolides and tetracyclines, is a serious and rapidly
growing problem worldwide. In the Asian Network for
Surveillance of Resistant Pathogen study, Song et al. [17]
demonstrated that Asian regions had the highest levels
of S. pneumoniae antibiotic resistance. A total of 59.3%
of erythromycin-resistant pneumococcal isolates were
observed in Asian countries. Vietnam had the highest
resistance rate, followed by Taiwan, Korea, Hong Kong,
and the hinterlands of China [18]. The erythromycin re-
sistance rate of S. pneumoniae in 1998 to 1999 in Beijing
was 71.0% [19], which was much higher than that in
1996 to 1997 [18]. Pneumococci data of hospitalized
pediatric patients with respiratory infections showed
85.7% erythromycin resistance in Shanghai [20] and
92.1% in Chongqing [21]. In the present study, the
erythromycin resistance rate of S. pneumoniae was
higher at 96.4%, and most of the isolates had high MICs














0 to 2 years 2 
Figure 2 Distribution of sequence types (STs) with age in the 135 erypneumococcal erythromycin resistance in the hinterlands
of China. Geographical variations were observed in the
phenotypic and genotypic characteristics of erythromycin-
resistant S. pneumoniae. The ermB gene was the most
common mechanism for erythromycin resistance in the
hinterlands of China, Taiwan, Sri Lanka, and Korea, simi-
lar to the results of this study for the children in Beijing.
However, the mef gene was more common in Hong Kong,
Singapore, Thailand, and Malaysia [18]. In Europe, the
ermB gene was the dominant macrolide-resistance gene,
especially in France, Spain, Switzerland, and Poland. On
the other hand, the mef gene was common in Greece
and Germany [22]. In the present study, the MLSB
phenotype was the predominant phenotype among the
erythromycin-resistant pneumococcal isolates, which was
in accordance with previous studies in China [23,24].
However, the M phenotype was more prevalent than the
MLSB phenotype in other countries, such as in Canada
and in the United Kingdom [9,25].
The resistance of S. pneumoniae to tetracycline was
also significantly high in China, which was similar to
that of erythromycin. This result may be related to the
abuse of tetracycline in agriculture and edible animals.2572 236 386 New Others
ce types (STs)
to 5 years    0 to 5 years
thromycin-resistant pneumococcal isolates.
Figure 3 Population snapshot of 135 erythromycin-resistant pneumococcal isolates as revealed by eBURST analysis. One spot indicates
one ST. The size of one spot corresponds to the number of pneumococcal isolates with the same ST. The lines indicate the presence of single
locus variant SLV links among particular STs.
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S. pneumoniae involving four cities in China revealed
that 82.1% of pneumococcal isolates were tetracycline-
resistant among 1-month-old to 5-year-old children with
acute upper respiratory infections [23]. The tetracycline
non-susceptible rate among the invasive erythromycin-
resistant pneumococcal isolates collected in Australia
was 75.5% [26]. This value was lower than the non-
invasive erythromycin-resistant isolates in the current
study. The present study, in addition to previous ones
[10,11,27], proved that the tetM gene was responsible
for tetracycline resistance in S. pneumoniae. In the
present study, we found that the eight pneumococcal
isolates with the tetM gene were susceptible to tetracyc-














0 to 2 years 2 to 5 years 0 to 5 years
PCV7: 33.3%, 53.1%, 45.2%
PCV13: 59.3%, 64.2%, 62.2%
Figure 4 Serotype distribution and vaccine coverage with age amongsequence of the tetM gene of one tetracycline-
susceptible isolate. This result was relative to the tetM
sequence in tetracycline-resistant isolates. Thus, further
studies are necessary.
Tetracycline resistance is associated with erythromycin
resistance in pneumococcal isolates, which are transmit-
ted by the transposons of the Tn916 or Tn917 family
including Tn6002, Tn2010, Tn3872, Tn1545, and Tn6003.
Tn6002, which was first detected in Streptococcus cristatus,
originated from the insertion of an ermB-containing DNA
fragment into Tn916, which carries the tetM gene [28,29].
Our study showed that Tn6002 was more common among
erythromycin-resistant isolates in Beijing children, which
accounts for 56.3%. In addition, Tn2010 is a composite




















0 to 2 years 2 to 5 years 0 to 5 years
the 135 erythromycin-resistant pneumococcal isolates.
Table 3 Sequence types, serotypes, macrolide-resistance genes, and transposons for 135 erythromycin-resistant
pneumococci
Clonal complex ST NO. Serotype (no.) Resistance genes (no.) Transposons (no.)
ermB ermB+mefE Tn6002 Tn2010 Tn3872 Tn1545/6003 None
CC271 271 16 19F (16) 16 15 1
320 9 19A (9) 9 8 1
236 4 19F (4) 4 4
1464 1 19F (1) 1 1
6993 1 19F (1) 1 1
7758 1 19F (1) 1 1
7766 1 19F (1) 1 1
CC2754 2754 2 6A (1), untyped (1) 2 2
7749 2 13/28 (2) 2 2
7752 1 untyped (1) 1 1
7762 1 6B (1) 1 1
CC200 200 1 14 (1) 1 1
876 12 14 (11), 19F (1) 10 2 9 2 1
CC230 230 1 non-23F (1) 1 1
7769 1 non-7A/F (1) 1 1
CC3173 3173 2 6A (2) 2 2
7756 1 6B (1) 1 1
CC3397 3397 3 15 (3) 3 3
7768 1 15 (1) 1 1
CC6202 6202 3 15 (3) 3 3
7750 1 15 (1) 1 1
CC855 855 1 6A (1) 1 1
7760 1 6A (1) 1 1
CC4640 4640 3 untyped (3) 3 3
7753 1 untyped (1) 1 1
Singletons 81 12 23F (11), non-23F (1) 11 1 11 1
386 4 6B (4) 4 4
2572 7 non-23F (6), 24/31/40 (1) 6 1 5 1 1
180 3 3 (3) 3 2 1
2912 2 6A (2) 2 2
3500 2 8 (2) 2 2
7759 2 untyped (2) 2 1 1
982 2 6A (2) 2 2
99 2 11A/C/D (1), 16/36/37 (1) 2 2
OTsa 28 untyped (6), othersb (22) 25 3 19 3 3 1 2
Total 135 94 41 76 39 7 8 5
a Other sequence types. Only one isolate was identified as each of the other STs.
b Other serotypes included 3 (1), 6A (1), 6B (3), non-7A/F (1), 10B/C/F (1), non-12B/F (1), 14 (1), 15 (4), non-17F (1), non-19A/C/F (1), 19F (1), 23F (2), 13/28 (2),
21/39 (1), 24/31/40 (1).
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results from the insertion of the ermB-containing Tn917
transposon [30] into Tn916 [31]. Tn1545 and Tn6003 have
similar compositions; they both contain the kanamycinresistance gene aph3’-III aside from the erythromycin- and
tetracycline-resistance determinants ermB and tetM. In
this study, the transposons Tn3872 and Tn1545/Tn6003
were rare at approximately 11.1%, indicating that Tn3872
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erythromycin and tetracycline resistance in Beijing chil-
dren. Moreover, we also found five pneumococcal isolates
without transposon determinants that carried the ermB
and tetM genes or only ermB gene. Further studies are ne-
cessary to verify if these five isolates contain unknown
transposons.
Three conjugate vaccines, namely, PCV7, PCV10, and
PCV13, were introduced to prevent pneumococcal infec-
tions in children. PCV13 included serotypes 1, 3, 5, 6A,
7F, and 19A plus the PCV7 serotypes 4, 6B, 9V, 14, 18C,
19F, and 23F. In this study, the serotypes 23F, 19F, 14,
and 6B were common among S. pneumoniae from
Beijing children younger than five years. This result was
similar with the previous studies in China [20,32,33], but
different from that of the other European countries, in
which the serotypes 1, 3, 6A, 7F, and 19A were common
among pneumococcal isolates [34]. Since the introduction
of PCV7, the incidence of pneumococcal disease
because of PCV7-serotypes has significantly declined in
many countries. However, several countries have reported
an increased rate of pneumococcal disease in non-PCV7
serotypes. This phenomenon, termed ‘replacement’, is
associated with specific pneumococcal serotypes or clones
[35]. In China, the PCV7-serotypes were more popular
among children for two reasons: first, PCV7 has been
on the market for only four years in China since 2008.
Second, only about 1% of Chinese children use PCV7 for
their routine pneumococcal immunization. We found that
the PCV13 coverage of the erythromycin-resistant isolates
was higher than that of PCV7 among all children younger
than five years as well as the children aged 0 to 2 years
because of the high rates of serotypes 3, 6A, and 19A.
Moreover, the PCV7 coverage of children aged 2 to 5 years
was also significant higher than that of children aged 0 to
2 years. All these results indicate that PCV13 controls
the pneumococcal diseases caused by the erythromycin-
resistant isolates better than PCV7 for children, especially
those younger than two years.
Maiden et al. [36] introduced the MLST approach to
monitor the epidemiology of bacteria based on multi
locus enzyme electrophoresis. Enright and Spratt were
the first to apply MLST for pneumococcal studies [14].
The MLST database enables the global sharing of data
and helps in the exchange of data between different
laboratories. Thus, it can be used to monitor the
molecular epidemiology of S. pneumoniae worldwide. In
the present study, the prevalent STs were ST271, ST81,
ST876, and ST320. In Shanghai, ST236 and ST271 were
the most common STs for S. pneumoniae [37]. ST320,
ST271, and ST876 were the prevalent types among the
invasive pneumococcal isolates collected from 11 cities
in China [38]. In Norway, the frequent STs were ST199,
ST176, and ST36 among the isolates collected from thechildren attending daycare centers [39]. Several associa-
tions were found between STs, serotypes, and macrolide-
resistance genes in this study. The dominant STs of the
serotype 19F, 14, 23F, and 6B isolates were ST271,
ST876, ST81, and ST386, respectively. ST320 was more
common in children aged 0 to 2 years than in other age
groups and all were from the serotype 19A pneumococci.
Notably, ST320 was found to be the predominant type
among pneumococcal serotype 19A isolates from ten
Asian countries [40]. This suggests that ST320 has an
important function in pneumococcal diseases in children.
The ST320 clone of serotype 19A is expected to be more
prevalent worldwide because of the wide use of PCV7.
A systematic study showed that Taiwan19F-14 was one
of the two dominant clones for erythromycin-resistant
isolates in Asian regions [41]. Taiwan19F-14 (ST236), a
multidrug-resistant pneumococcal molecular epidemi-
ology network clone and one of the most main clones
causing invasive pneumococcal diseases in Asian coun-
tries [42], was associated with seven STs in this study,
ST236, ST271, ST320, ST1464, ST6993, ST7758, and
ST7766. ST236 is a single locus variant of ST271 and a
double locus variant of ST320. According to eBURST
analysis, both ST271 and ST320 belong to CC271, which
was the most common CC observed in this study.
CC271 emerged in the United States after the introduc-
tion of PCV7, and expressed both the ermB and mef
genes [41], as shown in the present study.
Conclusions
S. pneumoniae in children younger than five years in
Beijing presented high and significant resistance rates to
erythromycin and tetracycline. The ermB and tetM genes
were the main factors for pneumococcal erythromycin
and tetracycline resistance, respectively. Majority of the
erythromycin-resistant isolates exhibited the cMLSB phe-
notype and carries the ermB, tetM, xis, and int genes,
which suggested the spread of the transposons of the
Tn916 family. PCV13 provided higher serotype coverage
in the childhood pneumococcal diseases caused by the
erythromycin-resistant isolates better than PCV7. The inci-
dence of erythromycin-resistant S. pneumoniae among
children is continuously increasing; thus, further long-term
studies of their molecular characteristics are necessary.
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